Bath & Body Works, Inc. Declares Quarterly Dividend of $0.20 (NYSE:BBWI)

Bath & Body Works, Inc. (NYSE:BBWI) declared a quarterly dividend on Friday, February 7th,RTT News reports. Stockholders of record on Friday, February 21st will be paid a dividend of 0.20 per share on Friday, March 7th. This represents a $0.80 annualized dividend and a dividend yield of 2.14%.

Bath & Body Works has raised its dividend payment by an average of 21.1% annually over the last three years. Bath & Body Works has a dividend payout ratio of 20.1% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Bath & Body Works to earn $3.65 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 21.9%.

Bath & Body Works Trading Down 3.5 %

Bath & Body Works stock opened at $37.38 on Friday. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99. The company has a fifty day simple moving average of $37.75 and a 200 day simple moving average of $33.67. The company has a market cap of $8.10 billion, a P/E ratio of 9.12, a price-to-earnings-growth ratio of 1.01 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings results on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. The business had revenue of $1.61 billion during the quarter, compared to analysts’ expectations of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Bath & Body Works’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the company posted $0.48 earnings per share. On average, equities research analysts forecast that Bath & Body Works will post 3.26 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on BBWI. Morgan Stanley decreased their price target on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating on the stock in a report on Thursday, November 21st. Telsey Advisory Group reiterated an “outperform” rating and issued a $42.00 price target on shares of Bath & Body Works in a research note on Monday, November 25th. JPMorgan Chase & Co. boosted their target price on shares of Bath & Body Works from $39.00 to $41.00 and gave the stock a “neutral” rating in a report on Friday, January 24th. TD Cowen increased their price target on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research note on Thursday, December 12th. Finally, Argus restated a “hold” rating on shares of Bath & Body Works in a report on Friday, January 10th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have issued a buy rating to the company. Based on data from MarketBeat.com, Bath & Body Works presently has a consensus rating of “Moderate Buy” and an average target price of $43.19.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.